Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $153.7 million.

  • Lifecore Biomedical, Inc. \De\'s Non-Current Assets fell 1113.88% to $153.7 million in Q2 2025 from the same period last year, while for May 2025 it was $653.3 million, marking a year-over-year decrease of 320.08%. This contributed to the annual value of $153.7 million for FY2025, which is 1113.88% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Non-Current Assets stood at $153.7 million, which was down 1113.88% from $153.5 million recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Assets peaked at $356.6 million during Q2 2021, and registered a low of $153.5 million during Q1 2025.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Non-Current Assets averaged around $199.6 million, with its median value being $169.6 million (2023).
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Non-Current Assets surged by 16143.67% in 2021 and then plummeted by 5568.08% in 2022.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Non-Current Assets stood at $270.8 million in 2021, then tumbled by 42.05% to $156.9 million in 2022, then grew by 7.78% to $169.1 million in 2023, then grew by 2.62% to $173.5 million in 2024, then dropped by 11.45% to $153.7 million in 2025.
  • Its last three reported values are $153.7 million in Q2 2025, $153.5 million for Q1 2025, and $173.5 million during Q4 2024.